120 related articles for article (PubMed ID: 26876733)
1. Raised arterial blood pressure in neurokinin-1 receptor-deficient mice (NK1R(-/-) ): evidence for a neural rather than a vascular mechanism.
Moyes AJ; Stanford SC; Hosford PS; Hobbs AJ; Ramage AG
Exp Physiol; 2016 May; 101(5):588-98. PubMed ID: 26876733
[TBL] [Abstract][Full Text] [Related]
2. The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder.
Pillidge K; Heal DJ; Stanford SC
J Psychopharmacol; 2016 Sep; 30(9):848-55. PubMed ID: 27462087
[TBL] [Abstract][Full Text] [Related]
3. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
Yan TC; McQuillin A; Thapar A; Asherson P; Hunt SP; Stanford SC; Gurling H
J Psychopharmacol; 2010 Jan; 24(1):27-38. PubMed ID: 19204064
[TBL] [Abstract][Full Text] [Related]
4. Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.
Pillidge K; Porter AJ; Young JW; Stanford SC
J Psychopharmacol; 2016 Sep; 30(9):837-47. PubMed ID: 27097734
[TBL] [Abstract][Full Text] [Related]
5. The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.
Porter AJ; Pillidge K; Grabowska EM; Stanford SC
Eur Neuropsychopharmacol; 2015 Apr; 25(4):512-21. PubMed ID: 25703442
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of L-type Ca(v) channels with nifedipine differentially affects performance of wildtype and NK1R-/- mice in the 5-Choice Serial Reaction-Time Task.
Dudley JA; Weir RK; Yan TC; Grabowska EM; Grimmé AJ; Amini S; Stephens DN; Hunt SP; Stanford SC
Neuropharmacology; 2013 Jan; 64():329-36. PubMed ID: 22884624
[TBL] [Abstract][Full Text] [Related]
7. Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.
Yan TC; Hunt SP; Stanford SC
Neuropharmacology; 2009 Dec; 57(7-8):627-35. PubMed ID: 19748515
[TBL] [Abstract][Full Text] [Related]
8. A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice(1).
Porter AJ; Pillidge K; Tsai YC; Dudley JA; Hunt SP; Peirson SN; Brown LA; Stanford SC
Genes Brain Behav; 2015 Feb; 14(2):189-99. PubMed ID: 25558794
[TBL] [Abstract][Full Text] [Related]
9. The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.
Pillidge K; Porter AJ; Dudley JA; Tsai YC; Heal DJ; Stanford SC
Br J Pharmacol; 2014 Oct; 171(20):4785-96. PubMed ID: 25074741
[TBL] [Abstract][Full Text] [Related]
10. The influence of test experience and NK1 receptor antagonists on the performance of NK1R-/- and wild type mice in the 5-Choice Serial Reaction-Time Task.
Weir RK; Dudley JA; Yan TC; Grabowska EM; Peña-Oliver Y; Ripley TL; Stephens DN; Stanford SC; Hunt SP
J Psychopharmacol; 2014 Mar; 28(3):270-81. PubMed ID: 23845920
[TBL] [Abstract][Full Text] [Related]
11. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day.
Yan TC; Dudley JA; Weir RK; Grabowska EM; Peña-Oliver Y; Ripley TL; Hunt SP; Stephens DN; Stanford SC
PLoS One; 2011 Mar; 6(3):e17586. PubMed ID: 21408181
[TBL] [Abstract][Full Text] [Related]
12. Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance Test.
Porter AJ; Pillidge K; Stanford SC; Young JW
Behav Brain Res; 2016 Feb; 298(Pt B):268-77. PubMed ID: 26522842
[TBL] [Abstract][Full Text] [Related]
13. Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice.
Pillidge K; Porter AJ; Vasili T; Heal DJ; Stanford SC
Pharmacol Biochem Behav; 2014 Dec; 127():56-61. PubMed ID: 25450119
[TBL] [Abstract][Full Text] [Related]
14. Disruption of noradrenergic transmission and the behavioural response to a novel environment in NK1R-/- mice.
Fisher AS; Stewart RJ; Yan T; Hunt SP; Stanford SC
Eur J Neurosci; 2007 Feb; 25(4):1195-204. PubMed ID: 17331215
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial function masks increased sympathetic vasopressor activity in rats with metabolic syndrome.
Battault S; Meziat C; Nascimento A; Braud L; Gayrard S; Legros C; De Nardi F; Drai J; Cazorla O; Thireau J; Meyer G; Reboul C
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H497-H507. PubMed ID: 29127233
[TBL] [Abstract][Full Text] [Related]
16. Generation of a NK1R-CreER knockin mouse strain to study cells involved in Neurokinin 1 Receptor signaling.
Huang H; Kuzirian MS; Cai X; Snyder LM; Cohen J; Kaplan DH; Ross SE
Genesis; 2016 Nov; 54(11):593-601. PubMed ID: 27712014
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice.
Thorsell A; Schank JR; Singley E; Hunt SP; Heilig M
Psychopharmacology (Berl); 2010 Mar; 209(1):103-11. PubMed ID: 20112009
[TBL] [Abstract][Full Text] [Related]
18. Eugenol and liposome-based nanocarriers loaded with eugenol protect against anxiolytic disorder via down regulation of neurokinin-1 receptors in mice.
Siyal FJ; Memon Z; Siddiqui RA; Aslam Z; Nisar U; Imad R; Shah MR
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2275-2284. PubMed ID: 33832901
[TBL] [Abstract][Full Text] [Related]
19. Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
Schank JR; Tapocik JD; Barbier E; Damadzic R; Eskay RL; Sun H; Rowe KE; King CE; Yao M; Flanigan ME; Solomon MG; Karlsson C; Cheng K; Rice KC; Heilig M
Biol Psychiatry; 2013 Apr; 73(8):774-81. PubMed ID: 23419547
[TBL] [Abstract][Full Text] [Related]
20. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
Lau HY; Bhatia M
J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
